
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1084 | 987 | 1014 | 782 | 1143 | 2146 |
Fund Return | 8.38% | -1.28% | 1.36% | -7.85% | 2.7% | 7.93% |
Place in category | 41 | 90 | 51 | 32 | 13 | 3 |
% in Category | 21 | 48 | 29 | 28 | 30 | 16 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Hwabao WP CSI Medical Index | 6.3B | 4.54 | -15.09 | - | ||
Hwabao WP S&P Oil&Gas E&P QDII LOF | 3.69B | -1.30 | 10.00 | -0.45 | ||
Hwabao WP SP US Cosmt Eq QDIILOFCNH | 1.66B | -4.08 | 10.31 | - | ||
Hwabao WP S&P China A Bonus Idx A | 1.56B | -3.85 | 6.30 | - | ||
Hwabao WP S&P China A Bonus Idx C | 1.56B | -3.90 | 5.89 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Zhongou Medical and Health Hybrid A | 32.09B | 0.38 | -16.27 | - | ||
Zhongou Medical and Health Hybrid C | 32.09B | 0.25 | -16.95 | - | ||
E Healthcare Secotor | 5.01B | 5.61 | 1.70 | 8.18 | ||
Fullgoal Precision Medical Mix Fund | 4.18B | 7.20 | -1.68 | - | ||
BOC Innovative Health Care Alloc | 3.01B | 15.67 | -1.43 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Xizang Haisco Pharmaceutical A | CNE100001BC7 | 7.05 | 36.30 | +2.34% | |
Jiangsu Hengrui | CNE0000014W7 | 6.84 | 46.89 | -0.85% | |
Kelun Pharm A | CNE100000PW7 | 5.86 | 31.76 | +0.35% | |
Mabwell Shanghai Bioscience | CNE100005RD2 | 5.49 | 18.82 | -0.32% | |
Suzhou Zelgen Biopharma | CNE100003RP1 | 5.19 | 94.62 | -0.03% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review